Antibodies are the main course of therapeutics, due in large part for their capability to connect with distinct ligand conformations in an effort to elicit specific biological responses. However, discovery of latest molecules binding unique epitopes is time intensive and hard, especially for cases requiring a particular antibody-ligand orientation to https://davidj555fyp6.wikijournalist.com/user